AilsynBio and Dong-E-E-Jiao Sign Project Cooperation Agreement Empowering Traditional Medicine with AI to Open a New Chapter in the Health Industry

HONG KONG SAR - Media OutReach Newswire - 10 April 2026 - AilsynBio, an AI-driven drug discovery company, held an Innovative Project Cooperation Agreement Signing Ceremony today at the Hong Kong Science Park, announcing a project cooperation agreement with Dong-E-E-Jiao Co., Ltd. (000423.SZ). This partnership marks a profound cross-sector integration of Artificial Intelligence (AI) and traditional medicine, aiming to empower biopharmaceutical innovation through technological means.

The ceremony brought together influential leaders and experts from industry, academia, and research sectors, including senior representatives from China Resources Pharmaceutical Group, Hong Kong Science and Technology Parks Corporation (HKSTP), and The University of Hong Kong (HKU), to witness this significant milestone.

Dr. Bo Chen, Chief Scientific Officer of China Resources Pharmaceutical, noted:

"This collaboration with Dong-E-E-Jiao and AilsynBio is a key initiative for China Resources Pharmaceutical in advancing the modernization of Traditional Chinese Medicine (TCM). It represents a deep integration of industry, academia, and research in the field of 'AI + TCM' between Mainland China and Hong Kong. We look forward to leveraging scientific research and industrial resources from both regions to overcome the challenges of TCM's mechanisms of action and to pave an innovative path for TCM to evolve from empirical medicine to evidence-based medicine."

Mr. Liang Zheng, Vice President of Dong-E-E-Jiao, stated:

"As a core strategic product for Dong-E-E-Jiao, deepening the scientific value of Compound E-Jiao Syrup is crucial for our brand upgrade. This cooperation will strengthen the scientific foundation of our products in the field of women's health, helping Dong-E-E-Jiao accelerate into a new stage of 'reshaping TCM wisdom through technological innovation.'"

Mr. Pierre Wang, Managing Director of HKU Versitech Limited, stated:

"HKU Versitech is honored to witness this project cooperation between HKU spin-off AilsynBio Ltd. and China Resources Pharmaceutical subsidiary Dong-E E-Jiao, a partnership that exemplifies the successful translation of Hong Kong's top-tier academic research into high-impact industrial applications. This cooperation will continue to serve as a vital catalyst for the company's rapid international growth and its mission to scale cutting-edge biotechnology globally."

Looking ahead, the two parties will focus on three key collaborative directions:

1. Advancing AI-driven innovation: Leveraging AilsynBio's AI drug discovery platform to accelerate biopharmaceutical R&D processes.
2. Launching specialized research: Engaging in in-depth cooperation on the "Premature Ovarian Insufficiency (POI)" research project.
3. Promoting cross-border fusion: Exploring the integration of biotechnology, AI, and traditional medicine to jointly create a new paradigm for the health industry.

During the ceremony, AilsynBio and Dong-E-E-Jiao signed the agreement on behalf of their respective organizations. The signing was witnessed by Dr. Bo Chen, Chief Scientist of China Resources Pharmaceutical; Mr. Eric Or, Chief Ecosystem Development Officer of HKSTP; and Mr. Pierre Wang, Managing Director of HKU Versitech.

AilsynBio stated that this cooperation is not only a combination of cutting-edge technology and traditional medicine, but also a strategic layout for future healthcare innovation. By leveraging AI technology, the partnership aims to inject technological vitality into traditional medicine for the benefit of more patients.
Hashtag: #AilsynBio #昂心生物

https://ailsynbio.com/

The issuer is solely responsible for the content of this announcement.

About China Resources Pharmaceutical

China Resources Pharmaceutical Group Limited (Stock code: 03320.HK) stands as a premier, integrated pharmaceutical enterprise in China. Our comprehensive operations span the entire value chain, from R&D and manufacturing to distribution and retail. We host a robust portfolio of listed subsidiaries and maintain advanced innovation platforms dedicated to both chemical and biological pharmaceuticals. Our diverse products including chemical drugs, Traditional Chinese Medicine (TCM), biologics, health supplements, and medical devices, addressing a vast spectrum of therapeutic areas. We are the proud custodian of iconic brands such as "999", "Dong-E-E-Jiao", and "Jiangzhong". Guided by our mission to "Safeguard Human Health and Enhance Quality of Life," we are dedicated to evolving into a trusted, innovation-driven leader in pharmaceutical and healthcare sector.

About Dong-E E-Jiao

Dong-E E-Jiao Co., Ltd. (000423.SZ) is an enterprise engaged in the production and operation of E-Jiao and related products. As a subsidiary of state-owned China Resources Group, it is primarily involved in the R&D, production, and sales of E-Jiao and related Chinese patent medicines, health foods, and food products. The company, formerly known as Shandong Dong-E E-Jiao Factory, was established in 1952, listed on the Shenzhen Stock Exchange in 1996, and joined China Resources Group in 2005. The company houses the National Gelatin Traditional Chinese Medicine Engineering Technology Research Center and a postdoctoral research workstation. It is recognized as a National High-Tech Enterprise, a National Innovative Enterprise, a National Intangible Cultural Heritage Heritage Enterprise, and a National Traditional Chinese Medicine Culture Publicity and Education Base. Its products are sold not only in the domestic market but also in over 10 countries and regions, including Southeast Asia, Europe, and the Americas.

About AilsynBio

AilsynBio is an AI-native biotechnology company dedicated to the rational design of differentiated therapeutics. By combining artificial intelligence, physics-based modeling, and deep medicinal chemistry expertise, the company delivers end-to-end drug discovery solutions spanning novel target identification, mechanism-of-action elucidation, and lead design and optimization. Validated through collaborations with multiple top-tier pharmaceutical companies, AilsynBio's technology offers industry-leading predictive accuracy and enables the delivery of IND-ready candidate molecules with greater efficiency, higher success rates, and a fraction of the time and cost required by conventional approaches.

** This press release is distributed by Media OutReach Newswire through automated distribution system, for which the client assumes full responsibility. **

JAKARTA, INDONESIA - Media OutReach Newswire - 20 May 2026 - Green SM, Indonesia's first all-electric ride-hailing service, has partnered with the Traffic Corps of the Indonesian National Police (Korlantas Polri) to launch a large-scale driver safety and professional standards training program in Indonesia. The initiative begins with more than 300 driver partners and is expected to expand to approximately 7,000 participants nationwide this year.

Held at the Indonesia Safety Driving Center (ISDC) in Serpong on May 18, 2026, the program provided participants with practical instruction in defensive driving, emergency response, professional driving ethics, and Indonesian traffic regulations. The initiative combines classroom learning with hands-on exercises conducted in a controlled training environment at one of Indonesia's leading driving safety facilities. The program reflects Green SM's long-term commitment to building a professional driver network while promoting safer mobility experiences and higher service standards for Indonesian communities.

Since its launch in Indonesia in December 2024, Green SM had already implemented regular internal training programs for driver partners, focusing on safe driving practices, real-world situation handling, customer service standards, and traffic law compliance. Through this partnership, Green SM aims to further strengthen and standardize its training initiatives while also contributing to broader road safety awareness across Indonesia.

As of April 2026, Green SM vehicles have traveled more than 109 million kilometers across Indonesia, contributing to the reduction of approximately 20.9 thousand tons of CO2 emisssions, equivalent to the annual carbon absorption capacity of more than 964 thousand trees. As the company continues to expand, Green SM remains focused on supporting driver capability development and service quality initiatives to support safer and more reliable mobility experiences. Safety remains one of Green SM's core operational priorities, spanning driver training, service standards, and the overall customer journey across every ride.

Korlantas Polri, the national authority responsible for traffic management, law enforcement, and road safety education across Indonesia, is supporting the initiative as part of broader efforts to encourage safer and more disciplined driving practices nationwide.

This program marks an important first step in the collaboration between Green SM and Korlantas Polri. Both parties expect to explore additional initiatives in the future to promote responsible driving practices and contribute positively to Indonesia's evolving transportation ecosystem.

Mr. Deny Tjia, Managing Director of Green SM Indonesia, shared: "Our driver partners represent Green SM in every journey they complete. Through this program, we aim to strengthen their practical driving skills, road safety awareness, and service professionalism, while continuing to elevate the overall customer experience across Indonesia. At Green SM, safety is not only an operational standard, but also a long-term commitment embedded in how we develop and deliver our services in Indonesia. We are honored to work with Korlantas Polri and hope this collaboration can create meaningful benefits for both our drivers and the wider community."

Head of the Traffic Corps (Kakorlantas) of the Indonesian National Police, Inspector General Agus Suryonugroho, stated, "The training is part of an effort to promote road safety, security, order, and smooth traffic flow. This collaboration in enhancing driver capabilities is important as part of efforts to improve driver professionalism, as the driver aspect plays a crucial role. We hope this initiative can serve as a benchmark."

Through this initiative, Green SM and Korlantas Polri aim to promote higher standards of responsibility and professionalism that benefit drivers, passengers, pedestrians, and the broader transportation ecosystem across Indonesia.

Hashtag: #GreenSM

The issuer is solely responsible for the content of this announcement.

About GSM & Green SM

GSM (Green and Smart Mobility) is a pioneering company in electric mobility, founded by Phạm Nhật Vượng. The company is building an integrated mobility ecosystem powered by VinFast electric vehicles, intelligent technology, and a professional operating network.

The GSM ecosystem currently consists of four core companies:

• Green SM – GSM's all-electric ride-hailing brand.
• VinDT – the professional driver training and testing company.
• VinBus – the electric bus operating company.
• Green Future – the company providing electric vehicle rental solutions.

Green SM is GSM's global all-electric ride-hailing brand, offering high-quality transportation services using a 100% electric fleet of cars and motorbikes. Combining smart technology with a professional driver network, Green SM delivers a mobility experience that is safe, reliable, and environmentally responsible.

Green SM currently operates in Vietnam, Laos, Indonesia, and the Philippines, advancing GSM's mission to provide safe and dependable green journeys for everyone while helping shape a more sustainable future for urban transportation worldwide.

** This press release is distributed by Media OutReach Newswire through automated distribution system, for which the client assumes full responsibility. **

Deny Tjia, Managing Director of Green SM Indonesia, with Dirkamsel Korlantas Polri Brigadier General Pol. Prianto, following the signing of a MoU at the opening of Green SM's driver safety training program at ISDC Serpong, May 18, 2026.